Agrochemicals company Sharda Cropchem announced Q2FY26 results Revenue: Rs 929.1 crore compared to Rs 776.9 crore during Q2FY25, change 20%. EBITDA: Rs 138.9 crore compared to Rs 81.3 crore during Q2FY25, change 71%. EBITDA Margin: 15.0% for Q2FY26. PAT: Rs 74.4 crore compared to Rs 42.4 crore during Q2FY25, change 75%. Ramprakash Bubna, Chairman & MD, said: “In Q2FY26, we delivered robust revenue growth of 20% YoY to Rs 929 crore, mainly driven by volumes. NAFTA and Europe remains a key contributors in both volume and value terms. With input costs stabilizing and improving price dynamics, Gross Margins has expanded by 690 basis points to 34.5% and we expect GP Margins to remain in a similar range going ahead. We expect prices to go up going forward. EBITDA has grown by 71% to Rs ~139 crore with EBITDA Margins at 15.0% (improved by 450 bps on Y-o-Y basis). For FY26, we are on track to maintain healthy EBITDA margins in the range of 15–18%. We remain committed to accelerating product registrations in FY26, supported by a planned capital expenditure of Rs 450–500 crore. Our strong registration pipeline of 1,068 underscores our resilience and sustained growth focus, positioning us well for the long term.” Result PDF